Overview
Matthew Baltes is a primary care provider, practicing in Family Medicine in Cleveland, Ohio. Dr. Baltes is rated as an Experienced provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. His top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Maturity Onset Diabetes of the Young. Dr. Baltes is currently accepting new patients.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- HMO
- POS
- PPO
- HMO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- PPO
- HMO
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- INDEMNITY
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- MEDICARE MAPD
- MEDICARE SNP
Locations
2500 Metrohealth Dr, A107, Cleveland, OH 44109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Ashtabula County Medical Center
James Chillcott is a primary care provider, practicing in Family Medicine in Ashtabula, Ohio. Dr. Chillcott is rated as a Distinguished provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. His top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Hypertension, Familial Hypertension, and Xanthoma. Dr. Chillcott is currently accepting new patients.
Cleveland Clinic
David Wendt is a primary care provider, practicing in Family Medicine in Cleveland, Ohio. Dr. Wendt is rated as an Advanced provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. His top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Maturity Onset Diabetes of the Young. Dr. Wendt is currently accepting new patients.
Lodi Community Hospital
Kimberly Sheets is a primary care provider, practicing in Family Medicine in Lodi, Ohio. Dr. Sheets is rated as an Advanced provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. Her top areas of expertise are Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Familial Hypertension, and Hypertension. Dr. Sheets is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Diabetic Hyperglycemic Hyperosmolar Syndrome
- Familial HypertensionDr. Baltes isExperienced. Learn about Familial Hypertension.
- Glucocorticoid-Remediable AldosteronismDr. Baltes isExperienced. Learn about Glucocorticoid-Remediable Aldosteronism.
- High CholesterolDr. Baltes isExperienced. Learn about High Cholesterol.
- HypertensionDr. Baltes isExperienced. Learn about Hypertension.
- Maturity Onset Diabetes of the YoungDr. Baltes isExperienced. Learn about Maturity Onset Diabetes of the Young.